Heparin / Heparina Sódica 25,000 IU
| Product Overview | |
| Generic Name | Heparin / Heparina Sódica 25,000 IU |
| Brand Name(s) | INHEPAR®, MAYARIN®, HEP-25 |
| Form | box of 50 vials, 5mL solution for injection |
| Strength | 25,000 iu / 5 mL |
| Therapeutic Class | Anticoagulant; unfractionated heparin; antithrombotic agent; heparin group |
| ATC Code | B01AB01 |
| Manufacturing & Regulatory | |
| Manufacturer | Gland, INTAS, |
| Country | Mexico, India, EU |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.0622.00 |
| Free Sale Certificate | Yes, available as COPP/CPP |
| Logistics & Export | |
| MOQ | 50 units Min |
| Shelf Life | 24 Months |
| Storage | 20°C to 25°C / 68°F to 77°F, |
| Incoterms | EXW |
| Lead Time | 1–3 weeks |
| Documentation | |
| Certificate of Analysis (COA) | Yes, typically available as a lot/batch CoA |
| SDS | Upon Request, not publicly posted |
| CTD Summary | Full CTD dossier proprietary; available under commercial agreement/license |
Description
Priced per 50 = U$D 426.00
eparina sódica solución inyectable, 25,000 UI / 5 mL, concentración 5,000 UI/mL, envase con 50 frascos ámpula, CNIS 010.000.0622.00
Heparin sodium is a rapid-acting parenteral anticoagulant used for prophylaxis and treatment of venous thrombosis and pulmonary embolism, thromboembolic complications associated with atrial fibrillation, disseminated intravascular coagulation, prevention of clotting in arterial/cardiac surgery, peripheral arterial embolism, blood transfusion procedures, extracorporeal circulation, and dialysis.
